MGH Researchers Develop AI Tool to Predict Melanoma Recurrence
A team of scientists at Massachusetts General Hospital has developed a new tool that uses AI to predict which patients are most likely to experience a recurrence of melanoma. Read the blog to learn how this research may lead to more effective treatment for patients in the early stages of melanoma.
Comments
Post a Comment